Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MC.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LB.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LP.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.50.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MH.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LB.1.3.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.43NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JC.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDPNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.3.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.3.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.2.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LU.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LF.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LB.1.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LB.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MM.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.7.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.3.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LB.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.2.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.1.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.7.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.1.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.15NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LB.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDYNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.18.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.4.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.16.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LW.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LP.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17507.2China
LB.1.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.3.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
ML.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.100 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used